On April 24th, the @US_FDA issued a letter to the manufacturer of #Essure outlining conditions for submitting additional postmarket information to the agency. Find out more about more about this #MedicalDevice update: https://go.usa.gov/xvUfE   pic.twitter.com/vhYgkDJxWM

On April 24th, the @US_FDA issued a letter to the manufacturer of #Essure outlining conditions for submitting additional postmarket information to the agency. Find out more about more about this #MedicalDevice update: https://go.usa.gov/xvUfE  pic.twitter.com/vhYgkDJxWM
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news
More News: Medical Devices